Citation Impact

25 standout
Sub-graph 1 of 13

Citing Papers

Advancements and challenges in CAR T cell therapy in autoimmune diseases
2024 Standout
Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs
2024 Standout
2 intermediate papers

Works of S.M. Peña being referenced

Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial
2022
Itch in dermatomyositis: the role of increased skin interleukin-31
2018

Author Peers

Author Epidemiology Dermatology Pharmacology Rheumatology Last Decade Papers Cites
S.M. Peña 74 65 31 58 11 165
Julie Rat-Wirtzler 103 5 321
Jane Steen 10 6 237
John C. Schweitzer 1 23 393
Hany El-Shamy 1 1 5 8 717
Kyle Grayson 8 2 27 353

All Works

Loading papers...

Rankless by CCL
2026